1. Home
  2. LGHL vs CRIS Comparison

LGHL vs CRIS Comparison

Compare LGHL & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGHL

Lion Group Holding Ltd.

HOLD

Current Price

$0.68

Market Cap

862.9K

Sector

Finance

ML Signal

HOLD

Logo Curis Inc.

CRIS

Curis Inc.

HOLD

Current Price

$0.42

Market Cap

976.1K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGHL
CRIS
Founded
2015
2000
Country
Singapore
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
862.9K
976.1K
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
LGHL
CRIS
Price
$0.68
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $30.33
AVG Volume (30 Days)
408.6K
★ 6.0M
Earning Date
04-30-2024
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 91.57
EPS
★ N/A
N/A
Revenue
N/A
★ $9,898,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$604.76
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 31.50
52 Week Low
$0.22
$0.33
52 Week High
$9.54
$2,880.00

Technical Indicators

Market Signals
Indicator
LGHL
CRIS
Relative Strength Index (RSI) 29.11 32.07
Support Level $0.58 $0.33
Resistance Level $1.13 $1.60
Average True Range (ATR) 0.34 0.21
MACD -0.04 0.13
Stochastic Oscillator 3.97 2.00

Price Performance

Historical Comparison
LGHL
CRIS

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd provides an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, and Over-The-Counter (OTC) stock options trading business. It offers these services through its all-in-one Lion Brokers Pro app and a variety of other apps available on iOS, Android, PC, and Mac platforms. The company's clients are mostly well-educated and affluent Chinese investors residing both inside and outside the PRC (excluding the United States). Its operating segments are: OTC Stock option trading, which generates maximum revenue, CFD trading, TRS trading, and Other. Geographically, the company derives maximum revenue from Hong Kong.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: